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MutY, like many DNA base excision repair enzymes, contains a
[4Fe4S]2 cluster of undetermined function. Electrochemical stud-
ies of MutY bound to a DNA-modified gold electrode demonstrate
that the [4Fe4S] cluster of MutY can be accessed in a DNA-mediated
redox reaction. Although not detectable without DNA, the redox
potential of DNA-bound MutY is 275 mV versus NHE, which is
characteristic of HiPiP iron proteins. Binding to DNA is thus asso-
ciated with a change in [4Fe4S]3/2 potential, activating the
cluster toward oxidation. Given that DNA charge transport chem-
istry is exquisitely sensitive to perturbations in base pair structure,
such as mismatches, we propose that this redox process of MutY
bound to DNA exploits DNA charge transport and provides a DNA
signaling mechanism to scan for mismatches and lesions in vivo.
DNA repair proteins that contain a FeS redox cofactor areubiquitous (1–7), yet a role for these factors has been
lacking. Two examples, highly homologous (8), are MutY (1) and
endonuclease III (Endo III) (2, 9), base excision repair enzymes
from Escherichia coli (10). MutY, containing 350 residues, acts
as a glycosylase to remove adenine from G:A (11–13) and
7,8-dihydro-8-oxo-2-deoxyguanonsine:A mismatches (14–21);
Endo III removes pyrimidines damaged by ring saturation,
contraction, or fragmentation (22–29). Although MutY and
Endo III have dramatically different substrate recognition fea-
tures, they both contain a [4Fe4S]2 cluster (1, 2, 9) within a
Cys-X6-Cys-X2-Cys-X5-Cys loop located near the protein C
terminus (1, 9, 30). Based on sequence alignment, a loop defined
by the first two ligating cysteines, called the FCL, is proposed to
be a common element of DNA repair proteins (30), present
throughout phylogeny (31–37). The function, if any, for these
clusters remains undetermined, although the FCL has been
proposed as a structural element, aiding in DNA binding (9, 30,
38). Interestingly, however, MutY is capable of folding without
the cluster; the [4Fe4S]2 cluster adds no stability to the enzyme,
but it is critical for substrate binding and catalysis (39). The
solvent-accessible [4Fe4S]2 cluster of Endo III undergoes de-
composition with ferricyanide and is resistant to reduction,
with an estimated midpoint potential of 600 mV for the
[4Fe4S]2/1 couple (2, 38).
Here, we consider whether the [4Fe4S]2 cluster in MutY can
function in DNA-mediated charge transport (CT). Many labo-
ratories have probed DNA-mediated CT chemistry (40–42).
Using biochemical, spectroscopic, and electrochemical methods,
we have shown that CT through DNA can proceed over long
molecular distances in a reaction that is remarkably sensitive to
intervening dynamical base pair structure (43–50). DNA-
mediated CT has been shown to yield oxidative DNA damage
from a distance within nucleosome core particles (47) and HeLa
cell nuclei (51). DNA binding proteins and peptides have also
been shown to modulate and participate in long-range CT
chemistry (48, 49), raising the question of the physiological
relevance of DNA CT.
Methods
DNA-Modified Electrodes. Thiol-modified oligonucleotides were
prepared by using phosphoramidite synthesis as described (50,
52–57). Thiol-terminated linkers were attached to single-
stranded oligonucleotides, HPLC-purified, and hybridized to
their complements. Self-assembly of thiol-modified duplexes was
carried out (100 M duplex, 5 mM phosphate, 50 mM NaCl, pH
7, ambient temperature) without added Mg2, to create loosely
packed DNA films (52). After assembly of the duplexes, the
remaining exposed surface was passivated with mercaptohexa-
nol (100 mM). After backfilling, the electrode was rinsed with
MutY dilution buffer (20 mM sodium phosphate, pH 7.51 mM
Na2EDTA20% glycerol500 mM NaCl) and used for protein
binding and electrochemical experiments. MutY (800 M) was
added to the DNA-modified electrode and allowed to incubate
for 10 min at ambient temperature before investigation by
electrochemistry.
Protein Samples. Proteins fused to maltose-binding protein
(MBP) were used for the electrochemical studies owing to the
need for high protein concentrations. The MBP-MutY fusion
protein has similar activity as the WT with G:A and 7,8-dihydro-
8-oxo-2-deoxyguanonsine:A-containing duplexes but is stable at
much higher protein concentrations. The WT MutY or C199H
MutY gene was ligated into a pMAL-c2x expression vector (New
England Biolabs) to produce an N-terminal MBP fusion protein.
Both the mutant and WT MBP-MutY proteins were expressed
in E. coli and purified as described (58) with the exception of an
amylose column replacing the cation exchange column in the
chromatography step. Protein samples were diluted to the de-
sired concentrations by using a buffer of 20 mM sodium phos-
phate, pH 7.51 mM Na2EDTA20% glycerol500 mM NaCl.
Cyclic Voltammetry (CV). CV was carried out on 0.2-cm2 Au (111)
electrodes on mica by using a BAS (West Lafayette, IN) model
CV-50W electrochemical analyzer equipped with a low-current
module. Buffer and electrolyte conditions were 20 mM sodium
phosphate (pH 7.5), 1 mM Na2EDTA, 20% glycerol, 500 mM
NaCl, ambient temperature (800 M MutY). A scan rate of 50
mVsec was used in all experiments. A Ag wire reference
electrode and a Pt wire auxiliary electrode were used, and
potentials were recorded versus Ag wire (52). Ag wire was used
rather than a saturated calomel electrode because of the low
volume constraints in the protein experiments.
Results and Discussion
MutY Electrochemistry on DNA Films. The redox characteristics of
MutY-bound DNA were probed electrochemically on loosely
packed DNA films (Fig. 1). Protein electrochemistry has bene-
fited from experiments conducted on monolayers of adsorbed
species (59–63), and in our laboratory, electrochemistry on
loosely packed DNA-modified surfaces has been a particularly
useful method to probe proteinDNA interactions (52). A
thiol-terminated duplex SH-5-AGTACAGTCATCGCG [non-
specific DNA binding site, Kd (MutY) 250 nM (64)] was
prepared and used in modifying gold electrode surfaces (50, 52).
After passivation of the remaining gold surface with mercapto-
hexanol, the electrodes were incubated for 10 min at ambient
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temperature with 800 M MutY, expressed as a fusion protein
with MBP (see Methods). As evident in Fig. 2, CV of MutY at
the DNA-modified surface yields a pronounced electrochemical
signal at 275 mV versus NHE. This signal corresponds to 2
pmolcm2; the density of the DNA surfaces is 12 pmolcm2 as
measured by radioactive tagging (52, 53). The peak shape
suggests slow diffusive kinetics associated with this redox reac-
tion; the scan rate data yield a slow diffusion constant of1011
cm2sec. Similar CV data have been reported for cytochrome c
on an electrode modified with a substrate mediator (59, 60). The
electrochemical signal for MutY grows in over the 10-min
incubation time, and the signal persists as the MutY solution is
exchanged for MutY storage buffer; three solution exchanges are
needed for bound MutY to diffuse away, consistent with MutY
being bound to the DNA film. Moreover, MutY (800 M) at a
surface without DNA but coated with mercaptohexanol yields no
electrochemical signal. The DNA is therefore required to reduce
the protein electrochemically.
That the redox reaction of MutY is DNA-mediated rather
than that the DNA serves to locally concentrate MutY at the
gold surface is established in experiments where the intervening
DNA structure is perturbed (Fig. 3). No electrochemical signal
for MutY is observed at an electrode modified with the duplex
SH-5-AGTACAGTCATCGCG hybridized to a complement
incorporating an abasic site opposite the underlined cytosine
(64). It has been established that the presence of an intervening
abasic site or other DNA base-stacking perturbation attenuates
the reduction of intercalators bound to DNA films (50, 52, 57).
Given the attenuation in signal seen here on DNA surfaces
containing an abasic site, it is clear that the abasic site must
intervene between MutY and the gold electrode. It is not, then,
the case that MutY is simply delivered to the gold surface by
DNA binding. Indeed the MutY redox process is DNA-
mediated.
Is the redox reaction at the [4Fe4S]2 cluster of MutY? To
probe this question, we examined a mutant protein, C199H, also
expressed as a fusion with MBP, in which Cys-199 is mutated to
a histidine. C199H has similar activity, substrate specificity, and
structure as the WT, except for histidine ligation of the cluster
at position 199 (17, 65, 66). EPR and crystallography indicate
that coordination to the histidine is somewhat destabilized,
leading to loss of Fe with the partial formation of [3Fe4S]
clusters. With C199H MutY bound to a DNA-modified elec-
trode, we again observe a reversible cyclic voltammogram, but
the potential is shifted 70 mV negative (Fig. 4). This shift in
potential indicates that we are accessing the cluster of MutY in
Fig. 1. Schematic illustration of DNA-modified electrodes used in these studies
to determine the DNA-bound redox potential of MutY electrochemically.
Fig. 2. CV of 800 M MutY at a gold surface modified with the thiol-terminated duplex SH-5-AGTACAGTCATCGCG and passivated with mercaptohexanol.
(a) The redox potential of MutY measured in these experiments requires DNA binding. The CV of MutY at a surface modified with mercaptohexanol (MCH) only
(black) shows no redox process, whereas at a DNAMCH-modified Au surface (blue), the DNA-bound redox potential of MutY is 75 mV vs. Ag (275 mV vs.
NHE). (b and c) This electrochemical signal grows in with DNA-binding time (CVs for incubation from 1–10 min) (b) and persists as the MutY solution is exchanged
for pure buffer (20 mM sodium phosphate, pH 7.51 mM Na2EDTA20% glycerol500 mM NaCl) (c), indicating that MutY is bound to the DNA-modified surface.
Fig. 3. The redox chemistry of MutY is DNA-mediated. CV of 800 M MutY
at a surface modified with the thiol-terminated duplex SH-5-AGTACAGT-
CATCGCG hybridized to a fully base-paired complement (blue) versus a com-
plement with an abasic site opposite the red C is shown.
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these electrochemistry experiments; in all other respects, C199H
is electrochemically identical to the WT protein.
Redox Properties of MutY and HiPiP Iron Proteins. The redox po-
tentials for both the WT [4Fe4S] cluster and mutant bound to
DNA are consistent with those found in HiPiP ferredoxins and
small models (67, 68). Ferredoxins that contain [4Fe4S] clusters
generally use the 21 couple; HiPiP iron proteins instead
shuttle between the 32 forms. The electrochemical couple
we observe on the DNA electrodes is in fact in the range found
typically for the 32 couple of [4Fe4S] clusters of HiPiP
proteins (67–74). Although redox studies of Endo III suggested
that reduction of the [4Fe4S]2 must occur at potentials 600
mV versus NHE and oxidation could not be accomplished
without decomposition (2, 38), these studies were conducted in
the absence of DNA, where the FCL is accessible to solvent.
Because the [4Fe4S] cluster of MutY is in the 2 form in the
absence of DNA, owing to the change in DNA-bound redox
potential, a shift in equilibrium toward a mixture of clusters in
the 2 and 3 form is therefore expected in the presence of
DNA. UV-visible spectroscopy of MutY in solution shows a
small, but significant, increase in absorption at 410 nm that grows
in upon addition of DNA, consistent with formation of
[4Fe4S]3 (data not shown). Low-temperature EPR also yields
a signal consistent with [4Fe4S]3 in the presence of a DNA-
bound oxidant (E. Yavin, A. Boal, and J.K.B., unpublished
results). Furthermore, in the electrochemistry experiments on
DNA-modified electrodes, CV experiments in which the initial
potential is varied indicate that both oxidized and reduced
species are present initially. Chronocoulometry also reveals that
the CV signal is not completely reversible; there is somewhat
more electrochemical reduction than oxidation, consistent with
MutY in the 3 form having somewhat higher affinity for DNA.
These data all are consistent with the environment around the
[4Fe4S] cluster being altered upon DNA binding so as to favor
oxidation of the cluster.
Because [4Fe4S] cluster potentials are well known to be
extremely sensitive to environment beyond the ligating atoms, it
is reasonable that binding of the DNA polyanion would alter the
potential (67–74). Both biochemical and recent structural studies
indicate that the FCL resides along the DNA-bound interface (9,
30, 38, 75, 76). Electrostatic arguments would suggest that
binding of the DNA polyanion would stabilize an oxidized form
of the cluster. It is also noteworthy that the many aromatic
Fig. 5. Schematic model of long-range scanning for mismatches by MutY through DNA-mediated CT chemistry. (Upper) Nonspecific binding of MutY to DNA,
where binding is associated with a shift in redox potential of the [4Fe4S]2 cluster, leading to oxidation to the 3 form. Associated with cluster oxidation is
DNA-mediated CT to an alternately bound MutY, where reduction to the 2 cluster promotes dissociation of the protein. Because this CT process proceeds
without interruption by an intervening mismatch, the process constitutes a scan of this region of the genome. (Lower) Association of MutY to a region containing
a mismatch (red), where the associated stacking perturbation does not permit DNA-mediated CT to occur. Here, the protein is shown processively diffusing to
the mismatch site.
Fig. 4. CV of 800 M WT (blue) and C199H mutant (green) MutY at a gold
electrode modified with the thiol-terminated sequence SH-5-AGTACAGT-
CATCGCG hybridized to a fully base-paired complement. A70 mV potential
shift is observed with the cluster mutant.
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residues surrounding the cluster in MutY (1) are typically found
in HiPiP proteins (69–74); DNA binding would be expected to
further shield the cluster from solution and associated oxidative
decomposition in the 3 form. The change in potential on
histidine ligation is also consistent with a neutral nitrogen donor
stabilizing Fe(II); variations in potential of similar magnitude
have been observed in ferredoxin mutants where the coordinat-
ing residue is changed (77). Moreover, if a significant population
of DNA-bound protein had lost an Fe (66), a shift to more
negative potentials would also be expected (78).
The [4Fe4S] cluster of these base excision repair enzymes,
containing a unique ligating peptide sequence, is thus well
designed for its function: robust in solution as [4Fe4S]2, stable
to oxidizing and reducing conditions of the cell, but, once buried
within DNA, activated to carry out redox chemistry.
A Role for DNA CT in DNA Repair. Importantly, our electrochemical
data indicate that DNA-mediated CT involving the [4Fe4S]
cluster of MutY is feasible. The primary lesson learned from our
many studies of DNA CT chemistry is that DNA CT is exquisitely
sensitive to perturbations in base pair structure (43–50). Indeed
we have shown DNA CT electrochemistry as a diagnostic tool for
mutations and lesions in DNA (50, 57). Might DNA repair
proteins, MutY in particular, similarly exploit DNA CT to detect
mismatches and lesions in DNA?
Fig. 5 illustrates a model in which DNA-mediated CT is used
by the repair protein in scanning DNA for mismatches and
lesions. Based on results of others, within the cell, MutY contains
a [4Fe4S]2 cluster (2, 38, 39). On binding DNA nonspecifically,
as our results indicate, MutY undergoes a shift in redox poten-
tial, and the 32 couple becomes accessible, so that the
cluster may become oxidized and release an electron in a
DNA-mediated reaction. Upon oxidation, MutY could then
serve, through DNA-mediated CT, to reduce an alternate DNA
repair protein, perhaps another MutY, bound at a distant site
along the duplex. The electrochemistry data indicate that such a
DNA-mediated process is possible. Moreover, association of two
MutY equivalents on the DNA template has been proposed
based on kinetic experiments (79). In the reduced form, the
DNA affinity of MutY should be diminished, facilitating disso-
ciation of the protein from its DNA site. We propose that this
process, as described, constitutes a scan of this region of the
genome. Significantly, the region must be well stacked and
contain no mismatches or lesions for CT to occur. Also shown
is association of MutY to a region containing a mismatch, where
the associated stacking perturbation would not permit DNA-
mediated CT to occur. Here, the protein would remain associ-
ated with the DNA, processively diffusing to the mismatch site
on a slower time scale. Data in support of this slower processive
mechanism for MutY (80) as well as descriptive models (81, 82)
have also been reported. The CT scanning mechanism does not
obviate these schemes. Instead, the DNA CT scanning strategy
confines the search to a manageable regime within the genome.
Furthermore, although the specificity ratio, 10–1,000, of these
repair proteins for their target site versus well-matched DNA is
too low to explain preferential recognition of mismatches within
the genome, this small level of specificity is sufficient for target
binding within the subset of mismatch-containing strands.
Overall, this process provides a rationale for the widespread
distribution of redox cofactors in DNA repair proteins (1–7,
31–37). Through this route, the rapid scanning of the genome can
be accomplished by using few copies of repair protein. Signifi-
cantly, this DNA-mediated signaling strategy takes advantage of
the unique chemical characteristics of DNA CT. This chemistry
now requires consideration more generally with respect to
mechanisms of DNA repair and signaling in vivo.
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